ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
66.890,09
2,53%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Xencor Inc (XNCR)

  7. Xencor Inc (XNCR) News

XNCR

Xencor (XNCR)

Xencor Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XNCR
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
09/05/202422h09Business WireXencor Reports First Quarter 2024 Financial ResultsNASDAQ:XNCRXencor Inc
09/05/202422h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XNCRXencor Inc
09/04/202414h01Business WireXencor Appoints Bart Cornelissen as Chief Financial OfficerNASDAQ:XNCRXencor Inc
11/03/202420h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
11/03/202420h45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
11/03/202420h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
11/03/202420h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
07/03/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
07/03/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
07/03/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
07/03/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
07/03/202422h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
07/03/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
06/03/202420h39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
06/03/202414h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
05/03/202422h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
05/03/202422h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
05/03/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
28/02/202422h01Business WireXencor to Present at Upcoming Investor ConferencesNASDAQ:XNCRXencor Inc
27/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
27/02/202422h01Business WireXencor Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:XNCRXencor Inc
20/02/202422h31Business WireXencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical UpdateNASDAQ:XNCRXencor Inc
16/02/202423h43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XNCRXencor Inc
16/02/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
15/02/202400h54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XNCRXencor Inc
14/02/202420h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
13/02/202422h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
19/01/202420h40Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XNCRXencor Inc
03/01/202422h01Business WireXencor to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XNCRXencor Inc
 Showing the most relevant articles for your search:NASDAQ:XNCR

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
DBI
SDXP
SDAX
TG
ALV
Allianz
TG
RHM
Rheinmetall
TG
DBK
Deutsche Bank
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
CCOM
US500
US 500
COIN
SOLUSD
Solana
CCOM
US30
US 30
TG
NOV
Novo Nordisk
NASDAQ
MSFT
Microsoft
TG
MBG
MercedesBenz
DBI
TDXP
Tec DAX
TG
BAS
BASF
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten